Seely Lynn
CIK 1327111
Transactions on file
13
Open-market buys
1
Win rate (buys)
100%
1 scored
Avg % since filing (buys)
+1437.7%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | 2026-08-21 | LYEL Lyell Immunopharma, Inc. | President and CEO | Sale | 9,589 | $149.0K | -39.6% | open → |
| 2026-08-11 | 2026-08-10 | LYEL Lyell Immunopharma, Inc. | President and CEO | Sale | 390 | $5.6K | -34.6% | open → |
| 2026-06-15 | 2026-05-11 | LYEL Lyell Immunopharma, Inc. | President and CEO | Sale | 388 | $7.3K | -50.4% | open → |
| 2025-02-26 | 2025-02-10 | LYEL Lyell Immunopharma, Inc. | OfficerDirector President and CEO | Grant | 337,500 | $0.00 | — | open → |
| 2025-03-18 | 2025-03-14 | LYEL Lyell Immunopharma, Inc. | OfficerDirector President and CEO | Buy | 175,000 | $106.8K | +1437.7% | open → |
| 2025-06-24 | 2025-06-18 | BPMC Blueprint Medicines Corp | Director | Grant | 3,902 | $499.9K | — | open → |
| 2025-11-12 | 2025-11-10 | LYEL Lyell Immunopharma, Inc. | President and CEO | Sale | 412 | $6.6K | -41.8% | open → |
| 2025-07-21 | 2025-07-17 | BPMC Blueprint Medicines Corp | Director | U | 13,254 | — | — | open → |
| 2025-07-21 | 2025-07-17 | BPMC Blueprint Medicines Corp | Director | Disp. | 3,902 | — | — | open → |
| 2025-08-13 | 2025-08-11 | LYEL Lyell Immunopharma, Inc. | OfficerDirector President and CEO | Sale | 391 | $4.1K | -10.9% | open → |
| 2025-08-13 | 2025-08-12 | LYEL Lyell Immunopharma, Inc. | OfficerDirector President and CEO | Sale | 406 | $4.2K | -9.3% | open → |
| 2025-08-22 | 2025-08-21 | LYEL Lyell Immunopharma, Inc. | OfficerDirector President and CEO | Sale | 7,257 | $76.5K | -11.0% | open → |
| 2025-08-22 | 2025-08-20 | LYEL Lyell Immunopharma, Inc. | OfficerDirector President and CEO | Grant | 40,000 | $0.00 | — | open → |
